Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Frank

Showing results (111-120 of 140) with videos related to

Pageof 14
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2013
Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myelomaRobert Frank Cornell, Parameswaran Hari, Mei-Jie Zhang, et al.
Bioorganic & Medicinal Chemistry|October 18, 2015
Structure activity relationships of benzyl C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonistsJihyae Ann, Aeran Jung, Mi-Yeon Kim, et al.
American Heart Journal|September 2, 2008
Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trialLuigi Padeletti, Carmine Muto, Themistoclis Maounis, et al.
European Journal of Medicinal Chemistry|May 21, 2013
2-(3-Fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists: structure activity relationships of the 2-oxy pyridine C-regionShivaji A Thorat, Dong Wook Kang, HyungChul Ryu, et al.
Mabs|March 16, 2022
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodiesRahmad Akbar, Habib Bashour, Puneet Rawat, et al.
Bioorganic & Medicinal Chemistry Letters|January 19, 2015
6,6-Fused heterocyclic ureas as highly potent TRPV1 antagonistsWei Sun, Hyo-Shin Kim, Sunho Lee, et al.
Bioorganic & Medicinal Chemistry|September 17, 2013
TRPV1 antagonist with high analgesic efficacy: 2-Thio pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamidesTae-Hwan Ha, Hyungchul Ryu, Sung-Eun Kim, et al.
Circulation|August 20, 2003
Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromesMichel Haïssaguerre, Fabrice Extramiana, Mélèze Hocini, et al.
European Journal of Medicinal Chemistry|February 10, 2015
Pyridine C-region analogs of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonistsHyungChul Ryu, Sejin Seo, Jee-Young Lee, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2015
α-Substituted 2-(3-fluoro-4-methylsulfonamidophenyl)acetamides as potent TRPV1 antagonistsPhuong-Thao Tran, Ho Shin Kim, Jihyae Ann, et al.
Pageof 14

Showing results (111-120 of 140) with videos related to

Sort By:
Pageof 14
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2013
Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myelomaRobert Frank Cornell, Parameswaran Hari, Mei-Jie Zhang, et al.
Bioorganic & Medicinal Chemistry|October 18, 2015
Structure activity relationships of benzyl C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonistsJihyae Ann, Aeran Jung, Mi-Yeon Kim, et al.
American Heart Journal|September 2, 2008
Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trialLuigi Padeletti, Carmine Muto, Themistoclis Maounis, et al.
European Journal of Medicinal Chemistry|May 21, 2013
2-(3-Fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists: structure activity relationships of the 2-oxy pyridine C-regionShivaji A Thorat, Dong Wook Kang, HyungChul Ryu, et al.
Mabs|March 16, 2022
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodiesRahmad Akbar, Habib Bashour, Puneet Rawat, et al.
Bioorganic & Medicinal Chemistry Letters|January 19, 2015
6,6-Fused heterocyclic ureas as highly potent TRPV1 antagonistsWei Sun, Hyo-Shin Kim, Sunho Lee, et al.
Bioorganic & Medicinal Chemistry|September 17, 2013
TRPV1 antagonist with high analgesic efficacy: 2-Thio pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamidesTae-Hwan Ha, Hyungchul Ryu, Sung-Eun Kim, et al.
Circulation|August 20, 2003
Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromesMichel Haïssaguerre, Fabrice Extramiana, Mélèze Hocini, et al.
European Journal of Medicinal Chemistry|February 10, 2015
Pyridine C-region analogs of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonistsHyungChul Ryu, Sejin Seo, Jee-Young Lee, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2015
α-Substituted 2-(3-fluoro-4-methylsulfonamidophenyl)acetamides as potent TRPV1 antagonistsPhuong-Thao Tran, Ho Shin Kim, Jihyae Ann, et al.
Pageof 14